Pharmaceutical and biotechnology companies are increasingly seeking to generate increased revenues from their non promoted, non strategic brands. These often vast portfolios of Established Brands usually have a mixed geographic footprint. Some have only been launched into a few markets, some have been launched and then discontinued or withdrawn from some or all markets. Healthcare professionals and patients in many cases still need access to many of the medicines. Effectively managing these disparate products and handling requests for access or information is challenging and time consuming. However, a little attention in the right area can produce significant results for both the company and the healthcare professional and their patients.

Idis has vast experience in managing Established Brands ensuring the best outcome for all key stakeholders. Idis’ Established Brands management offers a range of solutions for the management of mature licensed and unlicensed brands, including strategies for strategic market exit and discontinuations. Idis helps pharmaceutical companies to:

• Extend the lifecycle and commercial value of mature brands
• Maintain patient access through alternative, secure channels
• Establish an effective discontinuation strategy
• Minimize the impact on patients and healthcare professionals